ArticleScientific reports2023
Breast cancer survival prognosis using the graph convolutional network with Choquet fuzzy integral.
Article in Scientific reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Survival prediction landscape: an in-depth systematic literature review on activities, methods, tools, diseases, and databases.Frontiers in artificial intelligence · 2024Pooled it
- A Transformer-Based Deep Learning Approach to Predicting Air Organic Pollutant-Human Protein Interactions.Environmental science & technology · 2025Article
- Digital pathology and multimodal learning on oncology data.BJR artificial intelligence · 2024Review
- Deviation-support based fuzzy ensemble of multi-modal deep learning classifiers for breast cancer prognosis prediction.Scientific reports · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Breast cancer is the most prevalent kind of cancer among women and there is a need for a reliable algorithm to predict its prognosis. Previous studies focused on using gene expression data to build predictive models. However, recent advancements have made multi-omics cancer data sets (gene expression, copy number alteration, etc.) accessible. This has acted as the motivation for the creation of a novel model that utilizes a graph convolutional network (GCN) and Choquet fuzzy ensemble, incorporating multi-omics and clinical data retrieved from the publicly available METABRIC Database. In this study, graphs have been used to extract structural information, and a Choquet Fuzzy Ensemble with Logistic Regression, Random Forest, and Support Vector Machine as base classifiers has been employed to classify breast cancer patients as short-term or long-term survivors. The model has been run using all possible combinations of gene expression, copy number alteration, and clinical modality, and the results have been reported. Furthermore, a comparison has been made between the obtained results and different baseline models and state-of-the-art to demonstrate the efficacy of the proposed model in terms of different metrics. The results of this model based on Accuracy, Matthews correlation coefficient, Precision, Sensitivity, Specificity, Balanced Accuracy, and F1-Measure are 0.820, 0.528, 0.630, 0.666, 0.871, 0.769, and 0.647, respectively.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.